In addition, supportive secondary endpoints included a BMI reduction of at least 10%, a change in BMI as a percentage of the 95th percentile according to age-adjusted and sex-adjusted growth charts
As our Nurse Practitioner and wellness expert, Amanda Keil, puts it, Tirzepatide is a game-changer because of its dual mechanism
C., Franceschi, F., Russa, R
Medical weight loss with FDA-approved GLP-1 medications works differently because it addresses the hormonal drivers of appetite, not just willpower
That compares with a discontinuation rate of 11.3% among patients who took the highest dose
BPC-157 is studied for a broad cytoprotective and regenerative profile